A team of Duke and UNC researchers are providing expertise for a new clinical study in West Africa treating Ebola patients with transfusions of blood plasma from survivors of the virus.
The study, believed to be the first of its kind, enrolled its first patients three weeks ago and is being conducted at ELWA hospital operated by the Charlotte charity group SIM in Monrovia, Liberia. The main goal is to determine whether the approach is safe and effective in reducing the chances of dying from the disease.
“It all really becomes a team effort, and there are many people not directly involved who are willing to take on additional work, to allow us to do this in an emergency mode,” said Chris Woods, MD, MPH, professor of medicine (Infectious Diseases) and pathology and co-director of Duke’s Hubert-Yeargan Center for Global Health. Read more.
Robert Califf, MD, professor of medicine (Cardiology), has been named deputy commissioner for Medical Products and Tobacco at the Food and Drug Administration. Read more.
Duke Univeristy Health System announced that A. Eugene Washington, MD, will be the next chancellor for health affairs and the president and chief executive officer. Read more.
In addition, view highlights from 2014 on MedicineNews, the blog that continues to be the primary way the Department features the activities and accomplishments of faculty, trainees and staff. Take a moment to check out the top stories from the year.
Monitor the MedicineNews blog for news & updates from the Department of Medicine, School of Medicine and beyond.
Robert Lefkowitz, MD, received the Nobel Prize in Chemistry 2012 for research at Duke over 39 years. See photos and watch his Nobel lecture.
Visit DukeMedicine.org for information about patient care services offered by Duke Medicine.